Hospital · Private company
City of Hope Medical Center
Track this companyFree. Adds City of Hope Medical Center to your Dealase workspace and tells you when its record changes.
Clinical trials2525 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials25
- Removing the Planning Tumor Volume From Radiation Therapy for the Treatment of Head and Neck Squamous Cell CarcinomaNA · NOT_YET_RECRUITING · started Jun 22, 2027ClinicalTrials.gov NCT07926906 · fetched Nov 12, 2026
- Lenalidomide and Cosibelimab for the Treatment of Relapsed/Refractory Mycosis Fungoides or Sézary SyndromePHASE1 · NOT_YET_RECRUITING · started May 16, 2027ClinicalTrials.gov NCT07926893 · fetched Nov 12, 2026
- Intraoperative Neuromonitoring of Sacral Reflexes to Predict Post Operative Function in Patients Undergoing Sacrectomy for Pelvic Bone Malignancy or Patients Undergoing Spinal Procedures Without Sacral Root InvolvementNA · RECRUITING · started Jan 10, 2027ClinicalTrials.gov NCT07707024 · fetched Nov 12, 2026
- Evaluating the Effects of Propionate and Butyrate Supplementation on the Intestinal Health of Healthy VolunteersPHASE1 · NOT_YET_RECRUITING · started Jan 4, 2027ClinicalTrials.gov NCT07611370 · fetched Nov 12, 2026
- Scheduled Meditation for Improving Postoperative Outcomes in Patients Undergoing PancreatectomyNA · NOT_YET_RECRUITING · started Jan 1, 2027ClinicalTrials.gov NCT07608458 · fetched Nov 12, 2026
- Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaPHASE2 · RECRUITING · started Dec 19, 2026ClinicalTrials.gov NCT07582159 · fetched Nov 12, 2026
- Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell TransplantPHASE1 · RECRUITING · started Jun 12, 2026ClinicalTrials.gov NCT06996119 · fetched Nov 12, 2026
- Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell LymphomasPHASE1 · RECRUITING · started Dec 16, 2025ClinicalTrials.gov NCT07278856 · fetched Nov 12, 2026
- Nab-Paclitaxel PIPAC in Combination With Paclitaxel and Ramucirumab for the Treatment of Stomach Cancer With Peritoneal MetastasesPHASE1 · RECRUITING · started Oct 29, 2025ClinicalTrials.gov NCT06675136 · fetched Nov 12, 2026
- Glofitamab With Obinutuzumab Pre-treatment for the Treatment of Central Nervous System LymphomaPHASE1 · RECRUITING · started Jul 30, 2025ClinicalTrials.gov NCT06922604 · fetched Nov 12, 2026
- Virtual Reality Interventions for the Improvement of Depression, Anxiety and Pain in Patients With Head and Neck Cancer and CaregiversNA · RECRUITING · started Jun 25, 2025ClinicalTrials.gov NCT06985784 · fetched Nov 12, 2026
- PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate CancerPHASE1 · RECRUITING · started Oct 9, 2024ClinicalTrials.gov NCT05805371 · fetched Nov 12, 2026
- Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast CancerPHASE2 · RECRUITING · started Jul 23, 2024ClinicalTrials.gov NCT06260033 · fetched Nov 12, 2026
- Investigating the Feasibility and Acceptability of an Innovative Interdisciplinary Supportive Care Program: Couples Coping Together Against CancerRECRUITING · started Jul 5, 2024ClinicalTrials.gov NCT07664579 · fetched Nov 12, 2026
- Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic CancerPHASE1 · ACTIVE_NOT_RECRUITING · started Jun 10, 2024ClinicalTrials.gov NCT06454383 · fetched Nov 12, 2026
- Mezigdomide (CC-92480) Post Idecabtagene Vicleucel in Treating Patients With Relapsed Multiple MyelomaPHASE1 · ACTIVE_NOT_RECRUITING · started Apr 9, 2024ClinicalTrials.gov NCT06048250 · fetched Nov 12, 2026
- CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid LeukemiaPHASE1 · RECRUITING · started Dec 7, 2023ClinicalTrials.gov NCT05672147 · fetched Nov 12, 2026
- Radiotherapy in Combination With Atezolizumab in Locally Advanced Borderline Resectable or Unresectable Cutaneous SCCPHASE1 · ACTIVE_NOT_RECRUITING · started Apr 19, 2022ClinicalTrials.gov NCT05085496 · fetched Nov 12, 2026
- Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple MyelomaPHASE2 · ACTIVE_NOT_RECRUITING · started Nov 24, 2020ClinicalTrials.gov NCT04508790 · fetched Nov 12, 2026
- Leflunomide for the Treatment of High-Risk Smoldering Multiple MyelomaEARLY_PHASE1 · ACTIVE_NOT_RECRUITING · started Oct 8, 2020ClinicalTrials.gov NCT04370483 · fetched Nov 12, 2026
- Telehealth for the Self-Management of Dietary Quality of Life in Patients After Stomach Cancer SurgeryNA · ACTIVE_NOT_RECRUITING · started Jan 21, 2020ClinicalTrials.gov NCT05203627 · fetched Nov 12, 2026
- Enasidenib (AG-221) Maintenance Post Allogeneic HCT in Patients With IDH2 MutationPHASE2 · ACTIVE_NOT_RECRUITING · started Dec 23, 2019ClinicalTrials.gov NCT03728335 · fetched Nov 12, 2026
- CS1-CAR T Therapy Following Chemotherapy in Treating Patients With Relapsed or Refractory CS1 Positive Multiple MyelomaPHASE1 · ACTIVE_NOT_RECRUITING · started Apr 23, 2019ClinicalTrials.gov NCT03710421 · fetched Nov 12, 2026
- Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell LymphomaPHASE2 · ACTIVE_NOT_RECRUITING · started Dec 4, 2017ClinicalTrials.gov NCT03113500 · fetched Nov 12, 2026
- Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic LeukemiaPHASE2 · ACTIVE_NOT_RECRUITING · started Feb 10, 2014ClinicalTrials.gov NCT01885689 · fetched Nov 12, 2026